BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 17693123)

  • 1. Nuclear factor-kappaB1: regulation and function.
    Pereira SG; Oakley F
    Int J Biochem Cell Biol; 2008; 40(8):1425-30. PubMed ID: 17693123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical analysis of NF-kappaB signaling proteins IKKepsilon, p50/p105, p52/p100 and RelA in prostate cancers.
    Seo SI; Song SY; Kang MR; Kim MS; Oh JE; Kim YR; Lee JY; Yoo NJ; Lee SH
    APMIS; 2009 Aug; 117(8):623-8. PubMed ID: 19664134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The resolution of inflammation: anti-inflammatory roles for NF-kappaB.
    Lawrence T; Fong C
    Int J Biochem Cell Biol; 2010 Apr; 42(4):519-23. PubMed ID: 20026420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of p105 processing by NF-kappaB proteins in transiently transfected cells.
    Harhaj EW; Maggirwar SB; Sun SC
    Oncogene; 1996 Jun; 12(11):2385-92. PubMed ID: 8649779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NF-kappaB dimers in the regulation of neuronal survival.
    Sarnico I; Lanzillotta A; Benarese M; Alghisi M; Baiguera C; Battistin L; Spano P; Pizzi M
    Int Rev Neurobiol; 2009; 85():351-62. PubMed ID: 19607980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of different nuclear factor kappaB dimers on the survival of immortalized neural progenitor cells].
    Gui LL; Zhang CH; Liu ZH; Chen ZJ; Zhu C
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(13):871-5. PubMed ID: 18756949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology.
    Beinke S; Ley SC
    Biochem J; 2004 Sep; 382(Pt 2):393-409. PubMed ID: 15214841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-ischemic brain damage: NF-kappaB dimer heterogeneity as a molecular determinant of neuron vulnerability.
    Pizzi M; Sarnico I; Lanzillotta A; Battistin L; Spano P
    FEBS J; 2009 Jan; 276(1):27-35. PubMed ID: 19087197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipopolysaccharide from Salmonella enterica activates NF-kappaB through both classical and alternative pathways in primary B Lymphocytes.
    Souvannavong V; Saidji N; Chaby R
    Infect Immun; 2007 Oct; 75(10):4998-5003. PubMed ID: 17698569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted deletion of nuclear factor kappaB p50 enhances cardiac remodeling and dysfunction following myocardial infarction.
    Timmers L; van Keulen JK; Hoefer IE; Meijs MF; van Middelaar B; den Ouden K; van Echteld CJ; Pasterkamp G; de Kleijn DP
    Circ Res; 2009 Mar; 104(5):699-706. PubMed ID: 19168865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between activation of atypical NF-kappaB1 p105 signaling pathway and nuclear beta-catenin accumulation in colorectal carcinoma.
    Lauscher JC; Gröne J; Dullat S; Hotz B; Ritz JP; Steinhoff U; Buhr HJ; Visekruna A
    Mol Carcinog; 2010 Feb; 49(2):121-9. PubMed ID: 20027638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The nuclear I kappaB protein I kappaB zeta specifically binds NF-kappaB p50 homodimers and forms a ternary complex on kappaB DNA.
    Trinh DV; Zhu N; Farhang G; Kim BJ; Huxford T
    J Mol Biol; 2008 May; 379(1):122-35. PubMed ID: 18436238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The alternative NF-kappaB pathway from biochemistry to biology: pitfalls and promises for future drug development.
    Dejardin E
    Biochem Pharmacol; 2006 Oct; 72(9):1161-79. PubMed ID: 16970925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of NF-kappaB1 (p105/p50) attenuates unloading-induced downregulation of PPARalpha and PPARalpha-regulated gene expression in rodent heart.
    Razeghi P; Wang ME; Youker KA; Golfman L; Stepkowski S; Taegtmeyer H
    Cardiovasc Res; 2007 Apr; 74(1):133-9. PubMed ID: 17276423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The biological functions of NF-kappaB1 (p50) and its potential as an anti-cancer target.
    Yu Y; Wan Y; Huang C
    Curr Cancer Drug Targets; 2009 Jun; 9(4):566-71. PubMed ID: 19519322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unravelling the complexities of the NF-kappaB signalling pathway using mouse knockout and transgenic models.
    Gerondakis S; Grumont R; Gugasyan R; Wong L; Isomura I; Ho W; Banerjee A
    Oncogene; 2006 Oct; 25(51):6781-99. PubMed ID: 17072328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymulin and zinc (Zn2+)-mediated inhibition of endotoxin-induced production of proinflammatory cytokines and NF-kappaB nuclear translocation and activation in the alveolar epithelium: unraveling the molecular immunomodulatory, anti-inflammatory effect of thymulin/Zn2+ in vitro.
    Haddad JJ
    Mol Immunol; 2009 Dec; 47(2-3):205-14. PubMed ID: 19850345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of nuclear factor-kappaB p105/p50 in human melanoma and its role in cell migration.
    Gao K; Dai DL; Martinka M; Li G
    Cancer Res; 2006 Sep; 66(17):8382-8. PubMed ID: 16951147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Divergent C-terminal transactivation domains of Rel/NF-kappa B proteins are critical determinants of their oncogenic potential in lymphocytes.
    Fan Y; Rayet B; Gélinas C
    Oncogene; 2004 Feb; 23(5):1030-42. PubMed ID: 14647412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of naive T cell function by the NF-kappaB2 pathway.
    Ishimaru N; Kishimoto H; Hayashi Y; Sprent J
    Nat Immunol; 2006 Jul; 7(7):763-72. PubMed ID: 16732290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.